close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

1,063.12

+0.04%↑

JNJ

208.77

-0.11%↓

ABBV

226.66

+0.74%↑

UNH

333.66

+1.65%↑

AZN

91.6

+0.91%↑

LLY

1,063.12

+0.04%↑

JNJ

208.77

-0.11%↓

ABBV

226.66

+0.74%↑

UNH

333.66

+1.65%↑

AZN

91.6

+0.91%↑

LLY

1,063.12

+0.04%↑

JNJ

208.77

-0.11%↓

ABBV

226.66

+0.74%↑

UNH

333.66

+1.65%↑

AZN

91.6

+0.91%↑

LLY

1,063.12

+0.04%↑

JNJ

208.77

-0.11%↓

ABBV

226.66

+0.74%↑

UNH

333.66

+1.65%↑

AZN

91.6

+0.91%↑

LLY

1,063.12

+0.04%↑

JNJ

208.77

-0.11%↓

ABBV

226.66

+0.74%↑

UNH

333.66

+1.65%↑

AZN

91.6

+0.91%↑

Home・Aandelen Lijst・Avalo Therapeutics
Search

Avalo Therapeutics

Open

19.05 -0.63

Strong Buy

Prijsupdate 19 dec 2025, 17:32 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

17.96

Max

19.65

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+94.29% upside

Avalo Therapeutics Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

18 dec 2025, 23:54 UTC

Populaire aandelen

Stocks to Watch: Nike, Cassava Sciences, KB Home

DJ

Lezen

18 dec 2025, 23:51 UTC

Winsten

Nike Sales Tick Up in 2Q; China Weakness Persists -- Update

DJ

Lezen

18 dec 2025, 23:39 UTC

Belangrijke Marktbewegers

Cassava Sciences Shares Fall After FDA Places Hold on Epilepsy Drug Trial

DJ

Lezen

18 dec 2025, 22:57 UTC

Acquisities, Fusies, Overnames

TikTok Signs Agreement for Sale of U.S. Unit, Axios Reports, Citing a Memo

DJ

Lezen

18 dec 2025, 21:40 UTC

Winsten

Nike Sales Tick Up, But China Weakness Persists

DJ

Lezen

18 dec 2025, 23:45 UTC

Marktinformatie

Gold Steady, Supported by Fed Rate-Cut Prospects -- Market Talk

DJ

Lezen

18 dec 2025, 23:37 UTC

Marktinformatie
Winsten

Nike 2Q Results Fail to Convince Investors of Recovery -- Market Talk

DJ

Lezen

18 dec 2025, 23:36 UTC

Marktinformatie

Nikkei May Rise, Tracking Wall Street's Rally -- Market Talk

DJ

Lezen

18 dec 2025, 23:03 UTC

Acquisities, Fusies, Overnames

Mitsubishi Materials: Impact on Consolidated Results for FY Ending March 2026 Likely to be Immaterial

DJ

Lezen

18 dec 2025, 23:02 UTC

Acquisities, Fusies, Overnames

Mitsubishi Materials: To Acquire 4,448 Common Shares, 13,771 Preferred Shares of Co.

DJ

Lezen

18 dec 2025, 23:00 UTC

Acquisities, Fusies, Overnames

Mitsubishi Materials: Investment to Strengthen Recovery Network in U.S.

DJ

Lezen

18 dec 2025, 22:59 UTC

Acquisities, Fusies, Overnames

Mitsubishi Materials: Investment to Contribute to Expanding Collection Volume of Secondary Raw Material

DJ

Lezen

18 dec 2025, 22:58 UTC

Acquisities, Fusies, Overnames

SpaceX Could Go Public by Merging With EchoStar. It Isn't a Crazy Idea. -- Barrons.com

DJ

Lezen

18 dec 2025, 22:57 UTC

Acquisities, Fusies, Overnames

Mitsubishi Materials: Elemental USA E-Waste Operates E-Waste Recycling Business in U.S.

DJ

Lezen

18 dec 2025, 22:56 UTC

Acquisities, Fusies, Overnames

Mitsubishi Materials: To Acquire Portion of Shares of Elemental USA E-Waste & ITAD

DJ

Lezen

18 dec 2025, 22:55 UTC

Winsten

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

DJ

Lezen

18 dec 2025, 21:59 UTC

Winsten

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

DJ

Lezen

18 dec 2025, 21:50 UTC

Marktinformatie
Winsten

Tech, Media & Telecom Roundup: Market Talk

DJ

Lezen

18 dec 2025, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

18 dec 2025, 21:35 UTC

Winsten

FedEx's Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

DJ

Lezen

18 dec 2025, 21:31 UTC

Winsten

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

DJ

Lezen

18 dec 2025, 21:15 UTC

Winsten

Nike 2Q Europe, Middle East & Africa Rev $3.39B >NKE

DJ

Lezen

18 dec 2025, 21:15 UTC

Winsten

Nike 2Q Greater China Rev Down 17% >NKE

DJ

Lezen

18 dec 2025, 21:15 UTC

Winsten

Nike 2Q EPS 53c >NKE

DJ

Lezen

18 dec 2025, 21:15 UTC

Winsten

Nike 2Q Apparel Rev $3.91B >NKE

DJ

Lezen

18 dec 2025, 21:15 UTC

Winsten

Nike 2Q Equipment Rev $550M >NKE

DJ

Lezen

18 dec 2025, 21:15 UTC

Winsten

Nike 2Q N Amer Rev $5.63B >NKE

DJ

Lezen

18 dec 2025, 21:15 UTC

Winsten

Nike 2Q Footwear Rev $7.66B >NKE

DJ

Lezen

18 dec 2025, 21:15 UTC

Winsten

Nike 2Q Asia Pacific & Latin America Rev Down 4% >NKE

DJ

Lezen

18 dec 2025, 21:15 UTC

Winsten

Nike 2Q Greater China Rev $1.42B >NKE

DJ

Lezen

Peer Vergelijking

Prijswijziging

Avalo Therapeutics Prognose

Koersdoel

By TipRanks

94.29% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 37.4 USD  94.29%

Hoogste 48 USD

Laagste 25 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Avalo Therapeutics - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Gebaseerd op 5 analisten die aandelenratings hebben gegeven aan Avalo Therapeutics - Dist in de afgelopen 3 maanden.

Financieel

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,063.12

↑ +0.04%

JNJ

Johnson and Johnson

208.77

↓-0.11%

ABBV

AbbVie Inc

226.66

↑ +0.74%

UNH

UnitedHealth Group Inc

333.66

↑ +1.65%

AZN

AstraZeneca PLC ADR

91.6

↑ +0.91%
help-icon Live chat